Imperial College London

ProfessorGuyRutter

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Chair in Cell Biology
 
 
 
//

Contact

 

+44 (0)20 7594 3340g.rutter Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Awards

  • Albert Renold Award, EASD, 2020
  • Chair, EASD Islet Study Group organizing committee, 2019
  • Investigator Award, Wellcome Trust, 2018
  • Dorothy Hodgkin Lecture of Diabetes UK, Diabetes UK, 2014
  • Development of Multiscale analysis of pancreatic β-cell function by Imaging Islets in situ within the Intact Pancreas, Diabetes UK, 2012
  • Does the calcium sensor sorcin protect against glucolipotoxicity and beta cell failure in Type 2 diabetes, Diabetes UK, 2012
  • GLP-1-regulated beta cell connectivity in human and rodent islets: molecular mechanisms and role in type 2 diabetes, Diabetes UK, 2012
  • How the brain controls food intake: the emerging role of the brain GLP-1 system in energy balance and autonomic control, MRC, 2012
  • Novel approaches for imaging pancreatic beta cell mass in vitro and in vivo, Wellcome Trust /ICL ISSF, 2012
  • Potential role of Zip12 in regulation of hypoxia-induced pulmonary hypertension, BHF, 2012
  • Role of GWA genes in controlling pancreatic beta cell function and mass, MRC Programme Grant, 2012
  • Role of mitochondrial calcium transport in the regulation of insulin secretion, BBSRC, 2012
  • The role of long non-coding RNAs in regulating β-cell function and development, DRWF, 2012
  • Understanding pancreatic beta cell function in diabetes, Wellcome Trust Senior Investigator Award, 2012
  • Wellcome Trust Senior Investigator Award, Wellcome Trust, 2012
  • Control of glucagon secretion by AMPK and related kinases, Diabetes UK, 2011
  • Development of Multiscale analysis of pancreatic β-cell function by Imaging Islets in situ within the Intact Pancreas, EU Marie Curie CIG, 2011
  • Does LKB1 modulate wingless-type MMTV integration site (Wnt) signalling in pancreatic islet β cells, EFSD/MSD Fellowship, 2011
  • Role of the type 2 diabetes-associated zinc transporter SLC30A8/ZnT8 in the control of glucagon secretion, Diabetes UK, 2011
  • Royal Society Wolfson Merit Award, Royal Society, 2011
  • The type 2 diabetes-associated zinc transporter ZnT8 (SLC30A8) as a potential drug target, European Foundation for the Study of Diabetes (EFSD), 2011
  • Role of NAADP and TPC proteins in stimulus-secretion coupling in pancreatic β-cells, MRC Programme Grant, 2010
  • AMPK and the regulation of β-cell excitability, Juvenile Diabetes Research Foundation, 2009
  • Can genetic variation in microRNA sequences impact on the normal function of the pancreatic beta cell, Wellcome Trust Project Grant, 2009
  • Improving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetes - IMIDIA, EU FP7 Innovative Medicine Initiative, 2009
  • Role and regulation of PASK, Astra-Zeneca Sub contract to EU programme grant, 2009
  • British Heart Foundation Research Excellence Award, British Heart Foundation, 2008
  • Roles of ZnT8/SLC30A8 in insulin and glucagon secretion and in islet cell survival: final target validation, Servier IdRS, Paris, 2008
  • Director, Imperial Network of Excellence in Diabetes, Imperial College London

External Positions

  • Panel Member, Physiological Systems and Medicine Board, MRC, 2013 - 2016
  • Panel Member, MRC PSMB, MRC PSMB, 2013 - 2017
  • Panel Member, MRC Physiological Systems and Medicine Board (MRC-PSMB), MRC, 2013
  • Panel Member, Royal Society Newton International Fellowships Committee, Royal Society, 2013
  • Panel Member, Grants Advisory Panel, Diabetes UK, 2012 - 2015
  • Panel Member, Diabetes UK Grants Advisory Panel, Diabetes UK, 2012
  • Member, Wellcome Trust Peer Review College, Wellcome Trust, 2012
  • Panel Member, European Foundation for the Study of Diabetes (EFSD), 2009
  • Committee Member, Societé Francophone du Diabète (SFD, formerly “Alfediam”), 2009
  • Panel member, MRC College of Experts, 2005
  • Vice-chair from 2006; panel member from 2004., Wellcome Trust Physiological Sciences Board, 2004
  • European Molecular Biology Organisation - Fellowship interview panel, 2003
  • National Institutes of Health - Study Section on Islets and Diabetes, 2002 - 2002
  • Juvenile Diabetes Research Foundation International - Medical Science Review Committee, 2001
  • DiabetesUK - Studentships panel, 2000
  • Organisation Committee, American Diabetes Association Organisation Committee, American Diabetes Association
  • Panel member, Diabetes UK Grants Advisory Panel, Diabetes UK
  • Organising Committee, European Association for the Study of Diabetes Organising Committee, European Association for the Study of Diabetes
  • Panel Member, MRC Physiological Systems and Medicine Board (MRC-PSMB), MRC

Membership of Professional Bodies

  • Panel Member, LS4, ERC Advanced Grants, 2018
  • Chair for Colworth Medal, 2002
  • Elected member of the Biochemical Society Council, 2000 - 2003
  • Member of Biochemical Society Awards Committee, 2000
  • Member of European Association for the study of Diabetes, 1991
  • British Diabetic Association (Diabetes UK), 1990
  • BiochemicalSociety, 1986

Links with Other Academic Bodies

Industrial Connections

  • Astra Zeneca
  • Boehringer-Ingelheim, In part under the aegis of the EU FP7-supported Innovative Medicines Initiative in Diabetes, 'IMIDIA'
  • Cenix (Dresden, Germany)
  • Mellitech (Grenoble, France)
  • Novartis
  • Servier

Editorial Boards

  • Frontiers in Endocrinology, Diabetes: Molecular Mechanisms, Chief Section Editor, 2019
  • J Biol Chem, Editorial Board Member, 2014 - 2019
  • Diabetes Management, Editorial Advisory Board, 2010
  • Diabetes Research and Wellness Foundation, Panel Member, 2008
  • Islets, Editorial Board, 2008
  • Diabetes